OpenPharmaceutical productsde

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den Wirkstoffen Etanercept (ATC L04AB01) und Epoetin alfa/zeta (ATC B03XA01)[E12]

Düsseldorf, GermanyGWQ ServicePlus AG[E1]

In plain English

What they want: § 130a Abs. 8 bzw. § 130c Abs. 8 SGB V ermöglicht den Krankenkassen (KK) und pharmazeutischen Unternehmen, Rahmenrabattverträge über die zu Lasten der gesetzlichen KK abzugebenden Arzneimittel zu schließen. Die GWQ wird als Gesellschaft für Wirtschaftlichkeit und Qualität bei KK gem. § 130a Abs. 8 S. 5 SGBV für ihre Aktionärs- und Kundenkassen tätig.
Who can bid: No restrictions are stated in the notice data. The tender documents may set more.
Deadline: Buyer's deadline: 19 Oct 2028, 10:00 UTC+2. UTC: 19 Oct 2028, 08:00 UTC.
Published 26 Oct 2026.
Value: Not stated by the buyer.
Buyer: GWQ ServicePlus AGSee what else this buyer buys and when.
How to apply: Through the buyer's official process. Open the original notice on EU Tenders Electronic Daily (TED Search API) (opens in a new tab) ↗
Tender documents: We read the official TED notice. The full tender documents are on the buyer's own portal, linked from the notice, and we do not fetch them.

Tender documents, read for you

We read the official TED notice. The full tender documents are on the buyer's own portal, linked from the notice, and we do not fetch them.

Get the key points of the tender pack, with page references

A summary of what the documents require, a bid or no-bid checklist against your company profile, and answers to your questions with the page they come from.

Your tender documents

Download the tender pack from the buyer's portal (the invitation to tender, specification, selection questionnaire, scoring and draft contract) and add it here. We read every page and check it against your company for the bid assessment.

Deadline[E4]: 19 Oct 2028, 10:00 UTC+2
Value: Not stated
Published[E11]: 26 Oct 2026
Procedure[E10]: open
Source: EU Tenders Electronic Daily (TED Search API) (opens in a new tab)
Last checked: 3 hours ago

About the requirement

From the notice

§ 130a Abs. 8 bzw. § 130c Abs. 8 SGB V ermöglicht den Krankenkassen (KK) und pharmazeutischen Unternehmen, Rahmenrabattverträge über die zu Lasten der gesetzlichen KK abzugebenden Arzneimittel zu schließen. Die GWQ wird als Gesellschaft für Wirtschaftlichkeit und Qualität bei KK gem. § 130a Abs. 8 S. 5 SGBV für ihre Aktionärs- und Kundenkassen tätig. In Hinblick auf die dafür einschlägigen gesetzlichen Vorschriften zur Vergabe öffentlicher Aufträge, findet ein regelmäßiger Prozess wirkstoffbezogener, förmlicher Vergabeverfahren nach den Regularien des 4. Teils des GWB durch die GWQ ServicePlus AG statt. Die GWQ geht davon aus, dass dieses Verfahren auf Grund einer fehlenden Auswahlentscheidung und mithin der diskriminierungsfreien Zugangsmöglichkeit aller pharmazeutischen Unternehmen nicht in den Anwendungsbereich des Kartellvergaberechts fällt. Die GWQ ServicePlus AG beabsichtigt, federführend für die Krankenkassen der ARGE-OH-Bio Tech, nicht-exklusive Rabattvereinbarungen nach § 130a Abs. 8 SGB V mit Vertragsstart zum 01.01.2027 zu schließen. Folgende Krankenkassen gehören der ARGE-OH-BioTech an: - DAK-Gesundheit - Techniker Krankenkasse - Kaufmännische Krankenkasse - HEK - Hanseatische Krankenkasse - hkk - Handelskrankenkasse - GWQ ServicePlus AG (bevollmächtigt für die in Anlage 3 genannten Krankenkassen).[E5]

Eligibility and requirements

ConditionPlace of performance: NUTS DEA11.[E6]
ConditionSelection criterion (in deu): .[E7]
The notice data states no restriction on who may bid. Exclusion grounds and selection criteria in the tender documents still apply.

Risks and unknowns

UnknownThe notice does not state a value.
RiskThe official language is DEU. Documents and bids may need to be in that language.[E9]
UnknownWe read the published notice, not the full tender documents.

Updates

First seen · 28 Oct 2026, 09:19 UTC
The source published a call for competition with a future deadline.
Source document 743820-2026

Evidence

12 facts

Every fact on this page comes from the published notice. Each entry shows the document and the field it was read from.

E1
The buyer is GWQ ServicePlus AG.
Document 743820-2026, field /buyer-name/deu, read 28 Oct 2026, 09:19 UTC · source (opens in a new tab)
E2
The notice is classified under CPV 33600000.
Document 743820-2026, field /classification-cpv/0, read 28 Oct 2026, 09:19 UTC · source (opens in a new tab)
E3
The buyer is in DEU.
Document 743820-2026, field /buyer-country/0, read 28 Oct 2026, 09:19 UTC · source (opens in a new tab)
E4
Tenders must be received by 19 Oct 2028, 10:00 UTC+02:00.
“2028-10-19+02:00 10:00:00+02:00”
Document 743820-2026, field /deadline-receipt-tender-date-lot/0, read 28 Oct 2026, 09:19 UTC · source (opens in a new tab)
E5
The buyer describes the requirement (in deu).
“§ 130a Abs. 8 bzw. § 130c Abs. 8 SGB V ermöglicht den Krankenkassen (KK) und pharmazeutischen Unternehmen, Rahmenrabattverträge über die zu Lasten der gesetzlichen KK abzugebenden Arzneimittel zu schließen. Die GWQ wird als Gesellschaft für Wirtschaftlichkeit und Qualität bei KK…”
Document 743820-2026, field /description-proc/deu, read 28 Oct 2026, 09:19 UTC · source (opens in a new tab)
E6
Place of performance: NUTS DEA11.
Document 743820-2026, field /place-of-performance, read 28 Oct 2026, 09:19 UTC · source (opens in a new tab)
E7
Selection criterion (in deu): .
Document 743820-2026, field /selection-criterion-description-lot/deu, read 28 Oct 2026, 09:19 UTC · source (opens in a new tab)
E8
This notice changes or updates a call for competition. TED notice type: cn-standard.
Document 743820-2026, field /notice-type, read 28 Oct 2026, 09:19 UTC · source (opens in a new tab)
E9
The procedure title in deu is "Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den Wirkstoffen Etanercept (ATC L04AB01) und Epoetin alfa/zeta (ATC B03XA01)".
Document 743820-2026, field /title-proc/deu, read 28 Oct 2026, 09:19 UTC · source (opens in a new tab)
E10
The procedure type is open.
Document 743820-2026, field /procedure-type, read 28 Oct 2026, 09:19 UTC · source (opens in a new tab)
E11
TED published the notice on 27 Oct 2026.
“2026-10-27+01:00”
Document 743820-2026, field /publication-date, read 28 Oct 2026, 09:19 UTC · source (opens in a new tab)
E12
The notice is titled "Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den Wirkstoffen Etanercept (ATC L04AB01) und Epoetin alfa/zeta (ATC B03XA01)".
Document 743820-2026, field /notice-title/eng, read 28 Oct 2026, 09:19 UTC · source (opens in a new tab)

Source: Tenders Electronic Daily (TED), © European Union. Reuse authorised under Commission Decision 2011/833/EU. Data licence: EU reuse of TED data (Commission Decision 2011/833/EU) (opens in a new tab). Personal contact details in notices are not stored or shown.

Track this tender for free

Create a free account to save it, get alerts for tenders like it and see how well it fits your company.

Create a free account

No card needed. Already have one? Sign in

Full bid assessment

The notice is free. The assessment reads the tender documents against your company: pass/fail requirements you meet and miss, documents to prepare, how bids are scored, contract risks and a bid or no-bid recommendation. Every point quotes its page.

See a sample assessment

The buyer's documents for this notice are on their own portal. Download the tender pack there and upload it here.

Upload documents to get a full assessment

We check the notice at the source again before the report is produced. If it has closed or been cancelled by then, we do not produce the report and your payment is refunded.

Your fit

Original notice